TrialHuman vaccines & immunotherapeutics2014

Immunogenicity and safety of an inactivated 2012/2013 trivalent influenza vaccine produced in mammalian cell culture (Optaflu®): an open label, uncontrolled study.

Christof David Vinnemeier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.